Immunotherapy Targets Unique Antigens in Cancer

P

Peter Attia MD hosts a discussion with Steve Rosenberg.

ImmunityMedical

Quotes From Source

“We know it can work from multiple tumor types.”

Story of claim

Immunotherapy can treat various cancers by targeting unique antigens found in 80% of common tumors. T-cells recognize these antigens, allowing for precise treatment without high-frequency response.

  • Goal: To employ immunotherapy for treating diverse cancer types by targeting unique antigens.
  • Proof: Antigens recognized by T-cells are present on 80% of common cancers, enabling targeted immunotherapy.
  • Nuances:
    • 80% of common cancers have unique antigens
    • Neoantigens are present but not in high frequencies for isolated response
  • Impact on Life: Promising treatment for cancer patients, offering a targeted approach to combat tumors with unique antigens.

Investments

  • Price: $100,000-$200,000 per treatment cycle
  • Time: Months to years, depending on cancer type and response
  • Effort: High emotional and physical impact during treatment

Risks

Potential immune-related adverse effects; treatment efficacy varies by individual

Alternatives

  • Conventional chemotherapy
  • Radiation therapy

Get Started 🚀

  • Consult with an oncologist about immunotherapy suitability
  • Check for unique antigens in your tumor
  • Prepare for potential emotional and physical impacts

Brogevity AI can make mistakes. Check important info.

Reference Video